![Jonathan Goldman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jonathan Goldman
Chief Executive Officer at
Clinical Ink, Inc.
Net worth: 58 508 $ as of 2026-06-29
Profile
Jonathan H.
Goldman is currently Chief Executive Officer at Clinical Ink, Inc. since 2023.
Dr. Goldman is also a Director at Quadria Capital Investment Management Pte Ltd. and a Director at Astro Bidco Ltd. since 2018.
Former roles include Chief Executive Officer, Director & MD at Abzena Ltd. from 2018 to 2022, Chief Executive Officer at Aptuit LLC, Independent Director at Avalo Therapeutics, Inc. from 2024 to 2026, Chief Medical Officer & VP-Medical Affairs at POINT Biomedical Corp., Operating Partner at Welsh, Carson, Anderson & Stowe, and Associate Clinical Professor-Medicine at The University of California, San Francisco.
Education includes an MBA from The Trustees of Columbia University in The City of New York, undergraduate and doctorate degrees from the University of London, and an MBA from the University of California, Berkeley.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-27 | 3,166 ( 0.01% ) | 58 508 $ | 2026-06-29 |
Jonathan Goldman active positions
| Companies | Position | Start |
|---|---|---|
Astro Bidco Ltd.
 Astro Bidco Ltd. BiotechnologyHealth Technology Engages in integrated biopharmaceutical drug discovery, designing, optimization, manufacturing and chemistry services | Director/Board Member | 2018-08-12 |
Clinical Ink, Inc.
 Clinical Ink, Inc. Internet Software/ServicesTechnology Services Operates as an eSource platform and provides clinical trial solutions | Chief Executive Officer | 2023-02-12 |
Quadria Capital Investment Management Pte Ltd.
 Quadria Capital Investment Management Pte Ltd. Investment ManagersFinance Quadria Capital invests in companies located in Singapore, primarily in South and Southeast Asia. The firm targets companies operating in the fields of life sciences, medical technology and healthcare sectors and industries. It provides financing for growth stage capital requirements. | Private Equity Investor | - |
Former positions of Jonathan Goldman
| Companies | Position | End |
|---|---|---|
| AVALO THERAPEUTICS, INC. | Director/Board Member | 2026-06-01 |
| ABZENA PLC | Chief Executive Officer | 2022-10-12 |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Welsh, Carson, Anderson & Stowe
 Welsh, Carson, Anderson & Stowe Investment ManagersFinance WCAS invest in companies located in the United States. The firm targets companies operating in the fields of healthcare and technology sectors. It provide financing for acquisitions and growth capital requirements. | Private Equity Investor | - |
Aptuit LLC
 Aptuit LLC Miscellaneous Commercial ServicesCommercial Services Provides drug discovery, development and manufacturing support services | Chief Executive Officer | - |
Training of Jonathan Goldman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
73
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
POINT Biomedical Corp.
 POINT Biomedical Corp. Pharmaceuticals: MajorHealth Technology Develops biomedical-imaging products | Health Technology |
Aptuit LLC
Aptuit LLC Miscellaneous Commercial ServicesCommercial Services Provides drug discovery, development and manufacturing support services | Commercial Services |
Clinical Ink, Inc.
Clinical Ink, Inc. Internet Software/ServicesTechnology Services Operates as an eSource platform and provides clinical trial solutions | Technology Services |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Welsh, Carson, Anderson & Stowe
Welsh, Carson, Anderson & Stowe Investment ManagersFinance WCAS invest in companies located in the United States. The firm targets companies operating in the fields of healthcare and technology sectors. It provide financing for acquisitions and growth capital requirements. | Finance |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avalo Therapeutics, Inc.
 Avalo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for patients with unmet clinical need in immunology and rare genetic diseases | Health Technology |
Quadria Capital Investment Management Pte Ltd.
Quadria Capital Investment Management Pte Ltd. Investment ManagersFinance Quadria Capital invests in companies located in Singapore, primarily in South and Southeast Asia. The firm targets companies operating in the fields of life sciences, medical technology and healthcare sectors and industries. It provides financing for growth stage capital requirements. | Finance |
Abzena Ltd.
 Abzena Ltd. BiotechnologyHealth Technology Engages in discovery, development and manufactures biologics drugs | Health Technology |
Astro Bidco Ltd.
Astro Bidco Ltd. BiotechnologyHealth Technology Engages in integrated biopharmaceutical drug discovery, designing, optimization, manufacturing and chemistry services | Health Technology |
- Stock Market
- Insiders
- Jonathan Goldman
